The MTT Assay: How Cell Viability Is Measured In Vitro

Nearly every in-vitro study that asks a simple question — did this compound harm these cells, or leave them healthy? — starts with a viability number. For decades, the most common way to produce that number has been the MTT cell viability assay. It's fast, cheap, and reads out on equipment most labs already own, which is exactly why a percentage from an MTT plate turns up in so many characterization studies of compounds sold for research use only. Knowing how that percentage is generated is the difference between reading a study critically and taking a figure at face value.

This guide walks through what MTT is, the chemistry that makes it change color, how an experiment actually runs, how a viability percentage and an IC50 are read from the plate, what the assay genuinely measures, and where it can mislead. The aim isn't to run the experiment yourself. It's to read the results like someone who knows what produced them.

The Chemistry: From a Yellow Salt to Purple Formazan

What this section tells you: MTT works because living cells chemically transform it into a colored product, and dead cells cannot.

MTT is shorthand for 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, a pale-yellow compound in the tetrazolium family. Dissolved in growth medium, it's nearly colorless. The whole assay hinges on one reaction: metabolically active cells convert that yellow salt into an insoluble purple-blue pigment called formazan, while cells that have died leave it untouched. Because only living, working cells drive the change, the intensity of the color tracks the number of viable, metabolizing cells in the well.

Think of it as a chemical fuel gauge. A well full of healthy cells racks up a lot of purple pigment; a well where a compound has wiped out the population stays pale. Your eye can see the difference, but a spectrophotometer puts a precise number on it.

Early descriptions pinned the conversion on a single mitochondrial enzyme (succinate dehydrogenase), and you'll still see that shorthand in method sections. The modern picture is broader, and it matters for interpretation later in this article. One practical wrinkle showed up in the foundational work: different cell lines show different kinetics of formazan formation, which is why researchers build an individual calibration curve for each cell type rather than assuming one standard fits all.

How an MTT Experiment Is Run, Step by Step

What this section tells you: the workflow is four plain stages — grow, treat, develop color, read.

Seed and treat the cells

Cells are plated into the wells of a 96-well plate — a grid of small cups that lets one plate hold dozens of conditions at once — and given time to settle and attach. Each column typically gets a different concentration of the compound under study, so a single plate can map an entire concentration range against untreated control wells. The plate then goes back into the incubator for a defined exposure window.

Add MTT and let the color develop

After exposure, MTT is added to every well and the plate returns to the incubator for a few hours. During that time, the surviving cells quietly build up formazan pigment. The more living cells a well contains, the more purple it becomes.

Solubilize and read

Formazan is insoluble, so it forms crystals in and around the cells — no good for an even optical reading. A solubilizing agent fixes that. In one representative protocol, the formazan crystals are dissolved with dimethyl sulfoxide (DMSO) and the absorbance is read on a microplate reader. Readings are commonly taken around 570 nm, and near 595 nm in the DMSO-based version, because that's where dissolved formazan absorbs most strongly. The output is one absorbance value per well — a clean, comparable number standing in for how much living-cell metabolism happened there.

Reading the Result: Percent Viability and IC50

What this section tells you: raw absorbance becomes meaningful only in comparison to a control, and the summary figure researchers quote is usually the IC50.

An absorbance number on its own says little. It becomes informative when it's compared against untreated or vehicle-only control wells. In practice, the control absorbance is set to 100% viability, and every treated well is expressed as a percentage of it. A treated well reading half the control signal is reported as roughly 50% relative viability.

Plot those percentages against the concentration tested and a concentration-response curve takes shape — high viability where the compound is dilute, falling viability as concentration climbs. The single number researchers most often lift from that curve is the IC50: the concentration in the culture that lowers the signal to half of the control. It's a compact way to compare how strongly different compounds affect a given cell line in the dish. Read it strictly as a property of the cells-in-a-plate system — it describes what happened in culture, not an outcome in any living organism.

What the MTT Assay Actually Measures

What this section tells you: the signal reflects metabolic activity, not a literal headcount of cells — a distinction that changes how the numbers should be read.

It's tempting to treat an MTT reading as a cell counter, but that's not what it is. The color comes from enzyme activity. The reduction of MTT to formazan is mediated by oxidoreductase and dehydrogenase enzymes and by electron donors — mainly NAD(P)H — spanning the glycolytic pathway through to the mitochondrial electron transport chain. In other words, the assay reports the collective metabolic activity of the well, not a direct tally of individual cells.

That has a concrete consequence: the relationship isn't linear. As the same review notes, doubling the cell number doesn't simply double the absorbance, so a reading of "50%" is a statement about metabolic signal, not necessarily about exactly half the cells being present. It's a subtle but important reframing — the plate is measuring how busy the surviving population is, and metabolic busyness can shift for reasons that have nothing to do with cell count.

This is also why the specific readout of an assay matters. A viability assay like MTT reads bulk metabolism, whereas a technique such as ELISA for quantifying peptides reads the amount of one specific molecule. They answer different questions, and knowing which is which keeps a result from being over-interpreted.

Limitations and Sources of Error

What this section tells you: several ordinary experimental choices, and the chemistry of the test compound itself, can skew an MTT number in either direction.

Experimental confounders

Because the signal is metabolic, it's sensitive to conditions that have nothing to do with whether a compound is toxic. Seeding density, incubation time, washing steps, and media components such as phenol red and serum can all shift the reading. A washing step meant to clean up the plate can accidentally strip away formazan and pull the number down; long serum starvation can lower metabolic output without killing anything.

Compound interference and cell biology

The test compound can also react with the assay directly. In one systematic comparison, glycolysis inhibitors interfered with the tetrazolium dye and roughly doubled the absorbance, which would make a genuinely stressed population look healthier than it was. Nanoparticles and other reactive materials can produce similar artifacts. On the biology side, MTT and related tetrazolium assays do not measure the number of viable cells but an integrated set of enzyme activities tied to metabolism, and early-apoptotic cells can keep converting MTT even as they die — inflating the apparent count of healthy cells.

Best practice

The standard defenses are straightforward: include cell-free control wells to catch direct chemical interference, use phenol-red-free media, read at more than one timepoint rather than a single endpoint, and confirm important findings with a second, non-metabolic assay. Across the literature, the recommendation is consistent — pair MTT with an orthogonal method rather than trust it alone.

MTT vs Related Tetrazolium Assays

What this section tells you: newer tetrazolium salts trade the solubilization step for other tradeoffs, and non-tetrazolium assays sidestep metabolism entirely.

MTT has close relatives — MTS, XTT, and the WST family (WST-1, WST-8). The key chemical difference is solubility. MTT is membrane-permeable and forms an insoluble formazan that must be dissolved before reading, whereas MTS, XTT, and WST-1 are largely cell-impermeable, require an intermediate electron acceptor, and form water-soluble formazan. Those water-soluble versions skip the DMSO step, which is convenient — but the electron mediator they depend on can itself be toxic to cells, and XTT in particular is more sensitive to superoxide than MTT.

Other assays abandon tetrazolium chemistry altogether — resazurin reduction, sulforhodamine B (which stains total protein), and neutral red uptake. In head-to-head testing, MTT showed the widest variation in its linear range and high background at low cell densities compared with those alternatives. None of this makes MTT obsolete. It makes assay choice a compound-specific decision rather than a default.

Where MTT Fits Among In-Vitro Assays

What this section tells you: MTT answers one question well, and sits alongside other assays that answer different ones.

An MTT plate answers a specific question — are these cells alive and metabolizing after this treatment? — and it answers it cheaply and quickly. But that's one question in a much larger toolkit. When the research interest is how tightly a compound engages a target rather than whether cells survive, methods like radioligand binding assays measure receptor affinity, while the cAMP accumulation assay reads downstream signaling. For anyone working with research-grade compounds, the practical value is knowing which assay reports what — so a viability figure is weighed for exactly what it covers, and no more.

Frequently Asked Questions

What does the MTT assay actually measure?

It measures the metabolic activity of a cell population — specifically the rate at which cellular oxidoreductase and dehydrogenase enzymes, drawing on NAD(P)H, convert the tetrazolium salt MTT into colored formazan. Because that conversion happens only in metabolically active cells, the signal is treated as a proxy for viability, but it is not a direct count of living cells.

What wavelength is used to read an MTT assay?

Dissolved formazan is read on a microplate spectrophotometer, most commonly around 570 nm, though protocols using DMSO solubilization often read near 595 nm. A reference wavelength (for example 630–690 nm) is sometimes subtracted to correct for background.

Why is DMSO added in the MTT assay?

The purple formazan MTT produces is insoluble and forms crystals inside and around cells. A solubilizing agent such as dimethyl sulfoxide (DMSO) dissolves those crystals into a uniform colored solution so its absorbance can be measured accurately.

What is the difference between MTT and XTT or WST-8 assays?

MTT is membrane-permeable and forms an insoluble formazan that must be dissolved before reading. XTT, WST-1, and WST-8 are largely cell-impermeable, need an intermediate electron acceptor, and form water-soluble formazan — so they skip the solubilization step but introduce their own considerations, such as possible mediator toxicity.

What are the main limitations of the MTT assay?

It reports metabolic activity rather than cell number, so results are non-linear with cell count and sensitive to seeding density, incubation time, media components, and chemical interference from test compounds. Early-apoptotic cells can keep converting MTT, and some compounds react with the dye directly — which is why complementary, non-metabolic assays are recommended for confirmation.

The Bottom Line

The MTT assay endures because it does one thing well: it turns the invisible fact of cell metabolism into a number, fast and at low cost, using a microplate reader almost every lab already has. Read with its assumptions in mind, it's a dependable first look at how a compound affects cells in culture. Read carelessly — as a literal cell count immune to interference — it can mislead. The reliable move is to treat an MTT percentage as one signal among several, confirm the important results with an orthogonal assay, and always interpret the figure knowing exactly what generated it.

For research use only. Not for human or animal consumption of any kind. The information in this article is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. The statements made have not been evaluated by the U.S. Food and Drug Administration. These products are NOT FDA APPROVED. Please consult with a licensed healthcare professional before making any decisions regarding your health or research.

Optides LLC is a chemical supplier. Optides LLC is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic Act. Optides LLC is not an outsourcing facility as defined under 503B of the Federal Food, Drug, and Cosmetic Act.